Puma Biotechnology Inc (PBYI) — Capital Reinvestment Ratio
Puma Biotechnology Inc (PBYI) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($14.42 Million) in capital expenditures ($36.00K). Check PBYI tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Puma Biotechnology Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Puma Biotechnology Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Puma Biotechnology Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Puma Biotechnology Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Puma Biotechnology Inc from 2019 to 2025. See Puma Biotechnology Inc (PBYI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $41.80 Million | $71.00K | ▲ +18.0% |
| 2024 | 0.00x | $38.92 Million | $56.00K | ▼ -99.7% |
| 2023 | 0.47x | $27.01 Million | $12.64 Million | ▲ +966303.8% |
| 2021 | 0.00x | $20.65 Million | $1.00K | ▼ -100.0% |
| 2020 | 25.06x | $800.00K | $20.05 Million | ▲ +183130.9% |
| 2019 | 0.01x | $22.38 Million | $306.00K | — |